Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Le... von Robak, Tadeusz, Dmoszynska, Anna, Solal-Céligny, Philippe, Warzocha, Krzysztof, Loscertales, Javier, Catalano, John, Afanasiev, Boris V, Larratt, Loree, Geisler, Christian H, Montillo, Marco, Zyuzgin, Ilya, Ganly, Peter S, Dartigeas, Caroline, Rosta, András, Maurer, Jörg, Mendila, Myriam, Saville, M Wayne, Valente, Nancy, Wenger, Michael K, Moiseev, Sergey I

Volltext

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia von KNAUF, Wolfgang U, LISSICHKOV, Toshko, BECKER, Martin, FRICKE, Hans-Joerg, HUGUET, Francoise, DEL GIUDICE, Ilaria, KLEIN, Peter, TREMMEL, Lothar, MERKLE, Karlheinz, MONTILLO, Marco, ALDAOUD, Ali, LIBERATI, Anna, LOSCERTALES, Javier, HERBRECHT, Raoul, JULIUSSON, Gunnar, POSTNER, Gerhard, GERCHEVA, Liana, GORANOV, Stefan

Volltext

Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody von Mateu-Albero, Tamara, Juárez-Sánchez, Raquel, Loscertales, Javier, Mol, Wim, Terrón, Fernando, Muñoz-Calleja, Cecilia, Cuesta-Mateos, Carlos

Volltext

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial von Jones, Jeffrey A, Dr, Robak, Tadeusz, Prof, Brown, Jennifer R, MD, Awan, Farrukh T, MD, Badoux, Xavier, MBBS, Coutre, Steven, Prof, Loscertales, Javier, MD, Taylor, Kerry, MBBS, Vandenberghe, Elisabeth, Prof, Wach, Malgorzata, MD, Wagner-Johnston, Nina, Prof, Ysebaert, Loic, MD, Dreiling, Lyndah, MD, Dubowy, Ronald, MD, Xing, Guan, PhD, Flinn, Ian W, MD, Owen, Carolyn, MD

Volltext

Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL von Cuesta-Mateos, Carlos, Juarez-Sanchez, Raquel, Mateu-Albero, Tamara, Loscertales, Javier, Mol, Wim, Terron, Fernando, Munoz-Calleja, Cecilia

Volltext

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia von Cuesta-Mateos, Carlo, Fuentes, Patricia, Schrader, Alexandra, Juarez-Sanchez, Raquel, Loscertales, Javier, Mateu-Albero, Tamara, Vega-Piris, Lorena, Espartero-Santos, Marina, Marcos-Jimenez, Ana, Sanchez-Lopez, Blanca Andrea, Perez-Garcia, Yaiza, Jungherz, Dennis, Oberbeck, Sebastian, Wahnschaffe, Linus, Kreutzman, Anna, Andersson, Emma I., Mustjoki, Satu, Faber, Edgar, Urzainqui, Ana, Fresno, Manuel, Stamatakis, Kostantino, Alfranca, Arantzazu, Terron, Fernando, Herling, Marco, Toribio, Maria Luisa, Munoz-Calleja, Cecilia

Volltext

Effect of FCGR2A and FCGR3A variants on CLL outcome von Dornan, David, Spleiss, Olivia, Yeh, Ru-Fang, Duchateau-Nguyen, Guillemette, Dufour, Annika, Zhi, Jianguo, Robak, Tadeusz, Moiseev, Sergey I., Dmoszynska, Anna, Solal-Celigny, Philippe, Warzocha, Krzysztof, Loscertales, Javier, Catalano, John, Afanasiev, Boris V., Larratt, Loree, Rossiev, Viktor A., Bence-Bruckler, Isabelle, Geisler, Christian H., Montillo, Marco, Wenger, Michael K., Weisser, Martin

Volltext

Angioimmunoblastic T‐cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review von Iturrate, Isabel, Loscertales, Javier, Fernández‐Ruiz, Elena, Muñoz, Patricia, López, Consuelo, del Campo, Luciana, Muñoz, Cecilia, Alegre, Adrián

Volltext

S145: VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY von Al‐Sawaf, Othman, Robrecht, Sandra, Zhang, Can, Olivieri, Stefano, Chang, Yi Meng, Fink, Anna‐Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl‐Anton, Sivcheva, Liliya, Niemann, Carsten, Schwarer, Anthony, Loscertales Pueyo, Javier, Weinkove, Robert, Strumberg, Dirk, Kilfoyle, Allanah, Runkel, Eva, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten

Volltext

Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia von Alfonso‐Pérez, Manuel, López‐Giral, Sonia, Quintana, Nuria E., Loscertales, Javier, Martín‐Jiménez, Patricia, Muñoz, Cecilia

Volltext

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymp... von Chanan-Khan, Asher, Prof, Cramer, Paula, MD, Demirkan, Fatih, MD, Fraser, Graeme, MD, Silva, Rodrigo Santucci, MD, Grosicki, Sebastian, Prof, Pristupa, Aleksander, MD, Janssens, Ann, MD, Mayer, Jiri, Prof, Bartlett, Nancy L, Prof, Dilhuydy, Marie-Sarah, MD, Pylypenko, Halyna, MD, Loscertales, Javier, MD, Avigdor, Abraham, MD, Rule, Simon, Prof, Villa, Diego, MD, Samoilova, Olga, MD, Panagiotidis, Panagiots, Prof, Goy, Andre, MD, Mato, Anthony, MD, Pavlovsky, Miguel A, MD, Karlsson, Claes, MD, Mahler, Michelle, MD, Salman, Mariya, PhD, Sun, Steven, PhD, Phelps, Charles, MS, Balasubramanian, Sriram, PhD, Howes, Angela, PhD, Hallek, Michael, MD

Volltext

Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia von Robak, Tadeusz, Trelinski, Jacek, von Depka Prondzinski, Mario, Giagounidis, Aristoteles, Doyen, Chantal, Janssens, Ann, Román, Mayte Álvarez, Pueyo, Javier Loscertales, Ramos, Isidro Jarque, Loscertales, Javier, Rus, Gloria Pérez, Hellmann, Andrzej, Wiktor-Jedrzejczak, Wieslaw, Kuliczkowski, Kazimierz, Golubovic, Lana, Celeketic, Dusica, Cucuianu, Andrei, Gheorghita, Emanuil, Mihaela, Lazaroiu, Attias, Dina, Shpilberg, Ofer, Karyagina, Elena, Vilchevska, Kateryna, Svetlana, Kalinina, Cooper, Nichola, Talks, Kate, Prabhu, Mukyaprana, Prasad, Sripada V.S.S, Bharadwaj, T.P. Raghava, Flensburg, Mimi Folden, Petersen, Jorgen, Windyga, Jerzy

Volltext

Long-Term Follow-up of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia: A Single-Center Experience von García Herce, Cristina, Gómez García de Soria, Valle, Alonso, Alejandro, Feijóo, Samantha, García-Noblejas, Ana, Loscertales, Javier, Figuera, Angela, Steegmann, Juan Luis

Volltext

Abstract 4849: CAP-100: first-in-class anti-CCR7 antibody for CLL von Cuesta-Mateos, Carlos, Muñoz-Calleja, Cecilia, Loscertales, Javier, Terron, Fernando, Mol, Wim

Volltext

Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC) von Abrisqueta, Pau, Delgado, Julio, Alcoceba, Miguel, Oliveira, Ana Carla, Loscertales, Javier, Hernández‐Rivas, Jose A., Ferrà, Christelle, Cordoba, Raul, Yáñez, Lucrecia, Medina, Angeles, Motlló, Cristina, Iacoboni, Gloria, Villacampa, Guillermo, González, Marcos, Bosch, Francesc

Volltext

Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients von Labrador, Jorge, Cuevas, Maria Victoria, Alonso-Madrigal, Cristina, Zubiaur, Pablo, Azibeiro, Raul, Cuevas, Beatriz, Alvarez, Rodolfo, Diaz-Galvez, Francisco Javier, Gonzalez-Lopez, Tomas Jose, Alcaraz, Raquel, Mejía-Abril, Gina Paola, Loscertales, Javier, Abad, Francisco, Saiz-Rodríguez, Miriam

Volltext

CAP-100: First-in-class antibody for CCR7 + hematological malignancies von Cuesta, Carlos, Munoz-Callega, Cecilia, Loscertales, Javier, Terron, Fernando, Mol, Wim

Volltext

The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia von Al-Sawaf, Othman, Fürstenau, Moritz, Giza, Adam, Robrecht, Sandra, Von Tresckow, Julia, Fink, Anna Maria, Simon, Florian, Tausch, Eugen, Schneider, Christof, Sivcheva, Liliya, Schwarer, Anthony, Loscertales, Javier, Weinkove, Robert, Strumberg, Dirk, Kilfoyle, Allanah R., Juliusson, Gunnar, Da Cunha-Bang, Caspar, Illmer, Thomas, Gregor, Michael, Thornton, Patrick, Janssens, Ann, Tadmor, Tamar, Lindström, Vesa, Staber, Philipp Bernhard, Levin, Mark-David, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Ritgen, Matthias, Stilgenbauer, Stephan, Kater, Arnon P., Niemann, Carsten Utoft, Fischer, Kirsten, Eichhorst, Barbara F., Hallek, Michael

Volltext

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting... von Ferra, Christelle, Terol, María José, Marquet Palomanes, Juan, Ramírez Payer, Angel, Moreno, Carol, Osorio, Santiago, De la Cruz, Fátima, Garcia-Marco, Jose A., Ortiz, Macarena, Rios Herranz, Eduardo, Magnano, Laura, Iraheta, Sandra, Puerta, Jose Manuel, de la Serna, Javier, Smucler, Alicia, Arguiñano, Jose Maria, Loscertales, Javier, Muiña, Begoña, Fernández, Rubén, García, Tomas, Márquez, José A., Muntañola Prat, Ana, Perez Persona, Ernesto, Yáñez, Lucrecia, Pérez-Encinas, Manuel, González Díaz, Marcos, Caballero, Gonzalo, Andreu, María Angeles, Andreu, Rafael, Ruiz-Zorrilla, Ana, Moreno, Diana, Baltasar, Patricia

Volltext

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial von Knauf, Wolfgang U., Lissitchkov, Toshko, Aldaoud, Ali, Liberati, Anna M., Loscertales, Javier, Herbrecht, Raoul, Juliusson, Gunnar, Postner, Gerhard, Gercheva, Liana, Goranov, Stefan, Becker, Martin, Fricke, Hans-Joerg, Huguet, Francoise, Del Giudice, Ilaria, Klein, Peter, Merkle, Karlheinz, Montillo, Marco

Volltext